CpG island methylator phenotype in adrenocortical carcinoma: Fact or fiction?

Journal of Clinical Endocrinology and Metabolism

Volumn 98, Issue 1, 2013, Pages 48-50

  Liu Chittenden, Yi ^a   Kebebew, Electron ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA CATENIN; DNA; PROTEIN P53;

ADRENAL CORTEX CARCINOMA; CANCER PATIENT; CANCER PROGNOSIS; CPG ISLAND; DNA DETERMINATION; DNA METHYLATION; EDITORIAL; EPIGENETICS; GENE EXPRESSION; GENETIC ASSOCIATION; GENETIC CODE; GENETIC CORRELATION; GENETIC IDENTIFICATION; H19 GENE; HUMAN; PHENOTYPE; PRIORITY JOURNAL; PROMOTER REGION; TUMOR GENE;

ADRENAL GLAND NEOPLASMS; ADRENOCORTICAL CARCINOMA; CPG ISLANDS; DNA METHYLATION; FEMALE; HUMANS; MALE;

EID: 84872078313     PISSN: 0021972X     EISSN: 19457197     Source Type: Journal    
DOI: 10.1210/jc.2012-4063     Document Type: Editorial

References (17)

1. Grumbach MM, Biller BM, Braunstein GD, Campbell KK, Carney JA, Godley PA, Harris EL, Lee JK, Oertel YC, Posner MC, Schlechte JA, Wieand HS 2003 Management of the clinically inapparent adrenal mass ("incidentaloma") . Ann Intern Med 138:424-429
2. Bilimoria KY, Shen WT, Elaraj D, Bentrem DJ, Winchester DJ, Kebebew E, Sturgeon C 2008 Adrenocortical carcinoma in the United States: treatment utilization and prognostic factors. Cancer 113:3130-3136
3. Fassnacht M, Libé R, Kroiss M, Allolio B 2011 Adrenocortical carcinoma: a clinician's update. Nat Rev Endocrinol 7:323-335
4. Jain M, Rechache N, Kebebew E 2012 Molecular markers of adrenocortical tumors. J Surg Oncol 106:549-556
5. Berger SL, Kouzarides T, Shiekhattar R, Shilatifard A 2009 An operational definition of epigenetics. Genes Dev 23:781-783
6. Rechache NS, Wang Y, Stevenson HS, Killian JK, Edelman DC, Merino M, Zhang L, Nilubol N, Stratakis CA, Meltzer PS, Kebebew E 2012 DNA methylation profiling identifies global methylation differences and markers of adrenocortical tumors. J Clin Endocrinol Metab 97:E1004-E1013
7. Fonseca AL, Kugelberg J, Starker LF, Scholl U, Choi M, Hellman P, Åkerström G, Westin G, Lifton RP, Björklund P, Carling T 2012 Comprehensive DNA methylation analysis of benign and malignant adrenocortical tumors. Genes Chromosomes Cancer 51:949-960
8. Barreau O, Assié G, Wilmot-Roussel H, Ragazzon B, Baudry C, Perlemoine K, René-Corail F, Bertagna X, Dousset B, Hamzaoui N, Tissier F, de Reynies A, Bertherat J 2012 Identification of a CpG island methylator phenotype in adrenocortical carcinomas. J Clin Endocrinol Metab 98:174-184
9. Takai D, Jones PA 2002 Comprehensive analysis of CpG islands in human chromosomes 21 and 22. Proc Natl Acad Sci USA 99:3740-3745
10. Toyota M, Ahuja N, Ohe-Toyota M, Herman JG, Baylin SB, Issa JP 1999 CpG island methylator phenotype in colorectal cancer. Proc Natl Acad Sci USA 96:8681-8686
11. Teodoridis JM, Hardie C, Brown R 2008 CpG island methylator phenotype (CIMP) in cancer: causes and implications. Cancer Lett 268:177-186
12. Ragazzon B, Libé R, Gaujoux S, Assié G, Fratticci A, Launay P, Clauser E, Bertagna X, Tissier F, de Reyniès A, Bertherat J 2010 Transcriptome analysis reveals that p53 and β-catenin alterations occur in a group of aggressive adrenocortical cancers. Cancer Res 70:8276-8281
13. 2004 Finishing the euchromatic sequence of the human genome. Nature 431:931-945
14. Rollins RA, Haghighi F, Edwards JR, Das R, Zhang MQ, Ju J, Bestor TH 2006 Large-scale structure of genomic methylation patterns. Genome Res 16:157-163
15. Saxonov S, Berg P, Brutlag DL 2006 A genome-wide analysis of CpG dinucleotides in the human genome distinguishes two distinct classes of promoters. Proc Natl Acad Sci USA 103:1412-1417
16. Irizarry RA, Ladd-Acosta C, Wen B, Wu Z, Montano C, Onyango P, Cui H, Gabo K, Rongione M, Webster M, Ji H, Potash JB, Sabunciyan S, Feinberg AP 2009 The human colon cancer methylome shows similar hypo- and hypermethylation at conserved tissue-specific CpG island shores. Nat Genet 41:178-186
17. Issa JP 2004 CpG island methylator phenotype in cancer. Nat Rev Cancer 4:988-993